Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients.
CONCLUSIONS: Recurrent VA dysfunction was a novel independent risk factor for CV and composite ACM/CV events in HD patients, but not for VA abandonment. Patients with recurrent vascular dysfunction should be carefully monitored not only for VA patency but also for CV events.
PMID: 27398601 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Kim HJ, Lee H, Kim DK, Oh KH, Kim YS, Ahn C, Han JS, Min SK, Min SI, Kim HC, Joo KW Tags: Am J Nephrol Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Dialysis | Heart | Hemodialysis | Study | Thrombosis | Urology & Nephrology